Skip to main content
VIVA & The VEINS 2025 Main banner
VIVA25

CLTI Focus Track
CME

THE CURRENT STATE AND FUTURE OF TIBIAL DEVICES

Sunday, November 2, 2025
11:15am - 12:00pm PT

    Moderator(s)

  • Brian DeRubertis, MD

    Chief, Division of Vascular Surgery
    NewYork-Presbyterian / Weill Cornell Medical Center
    Vascular Surgery
    New York, New York, United States

  • Elizabeth Genovese, MD, MSc

    Assistant Professor of Surgery
    University of Pennsylvania
    Vascular Surgery
    Philadelphia, Pennsylvania, United States

Disclosure(s):
Brian DeRubertis, MD: No relevant disclosure to display
Elizabeth A. Genovese, MD, MSc: No relevant disclosure to display
Marianne Brodmann, MD: No relevant disclosure to display
Rabih Chaer, MD, MSc: No financial relationships to disclose
Jill Sommerset, RVT: No relevant disclosure to display
Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed: No relevant disclosure to display

Presentations:

  • 11:15am - 11:22am PT
    When, Where, and How to Incorporate DRS in Clinical Practice

    Speaker: Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed – Prince of Wales Hospital

  • 11:22am - 11:29am PT
    Current State of Below-the-Knee Clinical Trials

    Speaker: Marianne Brodmann, MD – Medical University Graz

  • 11:29am - 11:37am PT
    Panel Discussion
  • 11:37am - 11:44am PT
    Are There Advantages to Limus-Based Therapies in the Lower Leg?

    Speaker: Rabih Chaer, MD, MSc – Stony Brook Medicine

  • 11:44am - 11:51am PT
    How Should We Assess Perfusion Following Tibial Intervention?

    Speaker: Jill Sommerset, RVT – HOPE Vascular & Podiatry

  • 11:51am - 12:00pm PT
    Panel Discussion